BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,175,684 | +3.8% | 534,595 | +25.3% | 0.04% | +5.9% |
| Q2 2023 | $19,440,143 | -18.4% | 426,700 | -27.3% | 0.03% | -22.7% |
| Q1 2023 | $23,817,422 | -2.9% | 587,215 | +22.0% | 0.04% | -20.0% |
| Q4 2022 | $24,535,747 | +25.5% | 481,372 | +32.7% | 0.06% | +25.0% |
| Q3 2022 | $19,544,000 | -20.5% | 362,875 | -5.1% | 0.04% | -17.0% |
| Q2 2022 | $24,577,000 | +25.4% | 382,385 | +51.2% | 0.05% | +35.9% |
| Q1 2022 | $19,603,000 | -27.8% | 252,926 | -20.0% | 0.04% | -23.5% |
| Q4 2021 | $27,139,000 | +307.7% | 316,146 | +280.0% | 0.05% | +264.3% |
| Q3 2021 | $6,656,000 | -21.3% | 83,200 | -20.9% | 0.01% | -26.3% |
| Q2 2021 | $8,456,000 | +1750.3% | 105,182 | +1770.2% | 0.02% | +1800.0% |
| Q1 2021 | $457,000 | 0.0% | 5,624 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $457,000 | -89.3% | 5,624 | -89.5% | 0.00% | -91.7% |
| Q3 2020 | $4,268,000 | -75.8% | 53,338 | -73.7% | 0.01% | -78.2% |
| Q2 2020 | $17,611,000 | -2.1% | 202,899 | -8.3% | 0.06% | -16.7% |
| Q1 2020 | $17,982,000 | -4.7% | 221,204 | -1.5% | 0.07% | +17.9% |
| Q4 2019 | $18,861,000 | -26.4% | 224,471 | -23.4% | 0.06% | -15.2% |
| Q3 2019 | $25,619,000 | +8.1% | 292,861 | +1.3% | 0.07% | -14.3% |
| Q2 2019 | $23,696,000 | -11.9% | 289,229 | -12.4% | 0.08% | -14.4% |
| Q1 2019 | $26,903,000 | -10.7% | 330,090 | -21.4% | 0.09% | -15.9% |
| Q4 2018 | $30,137,000 | +30.7% | 420,192 | +40.4% | 0.11% | +27.4% |
| Q3 2018 | $23,052,000 | -27.4% | 299,369 | -30.4% | 0.08% | -22.2% |
| Q2 2018 | $31,742,000 | +101.8% | 429,868 | +77.8% | 0.11% | +80.0% |
| Q1 2018 | $15,726,000 | -47.6% | 241,763 | -48.0% | 0.06% | -42.3% |
| Q4 2017 | $30,026,000 | +4.2% | 464,515 | +0.0% | 0.10% | +2.0% |
| Q3 2017 | $28,825,000 | +13.3% | 464,463 | +10.5% | 0.10% | +1.0% |
| Q2 2017 | $25,447,000 | +55.8% | 420,332 | +33.5% | 0.10% | +40.3% |
| Q1 2017 | $16,334,000 | +31.8% | 314,951 | +12.8% | 0.07% | +20.0% |
| Q4 2016 | $12,389,000 | +68.6% | 279,242 | +80.9% | 0.06% | +62.2% |
| Q3 2016 | $7,348,000 | +22.5% | 154,384 | +16.4% | 0.04% | +2.8% |
| Q2 2016 | $5,998,000 | +93.7% | 132,658 | +75.9% | 0.04% | +89.5% |
| Q1 2016 | $3,097,000 | +39.4% | 75,401 | +29.5% | 0.02% | +35.7% |
| Q4 2015 | $2,222,000 | -35.8% | 58,235 | -44.7% | 0.01% | -56.2% |
| Q3 2015 | $3,459,000 | -73.2% | 105,280 | -42.9% | 0.03% | -72.6% |
| Q2 2015 | $12,903,000 | -14.8% | 184,510 | -16.5% | 0.12% | -10.7% |
| Q1 2015 | $15,140,000 | -8.2% | 221,091 | -1.7% | 0.13% | -10.3% |
| Q4 2014 | $16,485,000 | – | 224,949 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |